| Title |
Drug resistance results in alterations in expression of immune recognition molecules and failure to express Fas (CD95)
|
|---|---|
| Published in |
Immunology & Cell Biology, July 1998
|
| DOI | 10.1046/j.1440-1711.1998.00758.x |
| Pubmed ID | |
| Authors |
A Bhushan, JL Kupperman, JE Stone, PJ Kimberly, NS Calman, MP Hacker, RB Birge, TR Tritton, MK Newell |
| Abstract |
It is demonstrated that methotrexate/cisplatin-sensitive L1210 cells express low levels of major histocompatibility complex (MHC) class II relative to the high levels expressed on methotrexate (MTX)/cisplatin-resistant L1210/DDP cells. L1210 cells express cell-surface Fas, while the L1210/DDP cells express no cell-surface Fas. Expression of costimulatory molecules B7-1/B7-2 and Fas is increased on L1210 cells, but not L1210/DDP, in the presence of methotrexate or trimetrexate (TMTX). Therefore, a component of the mechanism of action of some anti-cancer agents may be to facilitate immune recognition and T cell-directed, Fas-induced cell death. Loss of cell-surface Fas expression and failure of Fas (CD95)-dependent apoptotic death has been observed when cells develop drug resistance. The defect in apoptosis can be overcome by anti-cancer agents or experimental manipulation that induce Fas expression on the drug-resistant cells. |
Login to access the Attention Digest and the Sentiment Analysis related to this output.
Mendeley readers
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Chile | 1 | 9% |
| Unknown | 10 | 91% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 7 | 64% |
| Student > Ph. D. Student | 1 | 9% |
| Researcher | 1 | 9% |
| Other | 1 | 9% |
| Unknown | 1 | 9% |
| Readers by discipline | Count | As % |
|---|---|---|
| Psychology | 4 | 36% |
| Agricultural and Biological Sciences | 2 | 18% |
| Neuroscience | 2 | 18% |
| Pharmacology, Toxicology and Pharmaceutical Science | 1 | 9% |
| Unknown | 2 | 18% |